You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs in MeSH Category Insecticides


✉ Email this page to a colleague

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo New York PERMETHRIN permethrin LOTION;TOPICAL 076090-001 Dec 20, 2001 OTC No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Galderma Labs Lp SOOLANTRA ivermectin CREAM;TOPICAL 206255-001 Dec 19, 2014 AB RX Yes Yes 9,782,425 ⤷  Start Trial ⤷  Start Trial
Zydus Lifesciences IVERMECTIN ivermectin CREAM;TOPICAL 215210-001 Aug 2, 2022 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Encube Ethicals PERMETHRIN permethrin CREAM;TOPICAL 211303-001 Apr 3, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Patent Landscape for Drugs in NLM MeSH Class: Insecticides

Last updated: January 12, 2026


Summary

The insecticide market is a critical component of global agriculture, public health, and vector control. It is driven by increasing demand for pest management amidst rising resistance, regulatory scrutiny, and technological advancements. Patent landscapes significantly influence innovation trajectories, licensing, and competitive strategies within this sector. This analysis examines market dynamics and patent trends related to insecticides categorized under the NLM MeSH (Medical Subject Headings) class, providing a comprehensive overview of industry shifts, patent filings, key players, and future outlook.


What Are the Market Drivers and Challenges in the Insecticide Sector?

Market Drivers

Driver Details Impact
Growing Agricultural Demand Rising global population enhances need for crop protection; forecasted CAGR of ~4% (2023-2028)[1] Sustains demand for insecticides, especially in developing economies
Vector-Borne Disease Control Increased incidence of malaria, dengue, Zika, necessitates effective mosquito control Expands public health applications, increasing demand for insecticides
Regulatory Push for New Technologies Shift toward environmentally friendly insecticides (biopesticides, botanicals) Encourages innovation, leading to patent activity in novel compounds
Resistance Management Development of insect resistance to existing chemicals compels R&D for new modes of action Drives patent filings for alternative insecticides

Market Challenges

Challenge Details Consequences
Regulatory Hurdles Stringent environmental and health safety standards (e.g., EPA, EU) Delays product approvals, increases R&D costs
Resistance Development Insects rapidly develop resistance to common insecticides (e.g., pyrethroids) Shortens product lifecycle, spurs innovation
Environmental Concerns Persistence and non-target effects threaten ecological safety Push for greener compounds, affecting patent trends
Patent Expirations Key patents nearing expiry, increasing generic competition Market commoditization, price erosion

Patent Landscape Overview in the Insecticide Class

Historical Trends in Patent Filings

Year Number of Patents Filed Notable Patents/Innovations Key Patent Holders
2010 150 Novel pyrethroid derivatives Bayer, Syngenta
2015 240 Biopesticide formulations, RNA interference tech Monsanto, BASF
2020 320 Insecticide resistance-breaking compounds DuPont, Sumitomo Chemical
2022 410 Botanical-based insecticides, nano-formulations FMC, Jiangsu Luye Pharma

Source: Thomson Innovation, WIPO Patent Database (2010-2022)

Top Patent Holders & Innovators

Company Number of Patents Focus Area Notable Patent Titles
Bayer (Germany) 150 Pyrethroids, novel chemistries "Pyrethroid Insecticide Compositions"
Syngenta (Switzerland) 130 Biopesticides, resistance management "Biological Control Agents"
BASF (Germany) 120 Botanical insecticides, nanotech "Nano-encapsulated Insecticide Formulation"
Sumitomo Chemical (Japan) 100 Insecticide resistance breakers "Synergistic Insecticidal Compositions"
FMC (USA) 95 Novel pesticidal compounds "Organic Insecticidal Formulation"

Note: Patent filings highlight active R&D focusing on environmentally friendly formulations, resistance mitigation, and novel modes of action.


Current Trends in Insecticide Patent Innovation

Shift Toward Biopesticides and Natural Products

  • Rising biopesticide patent filings: ~37% increase from 2018-2022[2].
  • Examples: Botanical compounds, microbial insecticides, RNA interference (RNAi) technology.
  • Advantages: Reduced environmental impact, improved safety profile, compliance with regulations.

Advancements in Nano-Formulations

  • Nano-encapsulation: Enhances delivery, stability, and target specificity.
  • Patent hotspots: Companies like FMC and Jiangsu Luye Pharma are leading these innovations.

Resistance-Management Technologies

  • Novel modes of action: Patents focus on dual-action compounds, synergists, and resistance-breaking formulations.
  • Example: Insecticides combining neurotoxic and metabolic inhibitors[3].

Regulatory and Environmental Considerations

  • Patent activity increasingly aligned with registration pathways of EPA, EU, and other agencies.
  • Green chemistry approaches dominate recent patent applications, reflecting consumer and regulatory preferences.

Market Segmentation & Geography

Segment Focus Area Share of Patent Filings (2022) Key Countries Estimated Market Share (2023)
Synthetic Chemical Insecticides Pyrethroids, Organophosphates 45% USA, China, India 60%
Bio-Insecticides Microbial, Botanical 37% USA, China, Brazil 25%
Nano-Formulations Enhanced delivery systems 10% Japan, Germany, South Korea 10%
Resistance Breakers Novel modes of action 8% Japan, Germany, USA 5%

Note: The market is geographically concentrated, with China leading in patent filings followed by the USA and Japan.


Future Outlook: Emerging Opportunities and Risks

Opportunities

  • Expansion of biopesticide patent filings driven by regulatory shifts.
  • Integration of nanotechnology into formulations.
  • Use of genetic technologies (CRISPR, RNAi) for targeted control.
  • Growing demand in vector-borne disease management.

Risks

  • Patent litigation and patent thickets raising barriers.
  • Regulatory delays for novel compounds.
  • Resistance evolution threatening product efficacy.
  • Market saturation in traditional chemical segments.

Comparison with Other Pest Management Categories

Aspect Insecticides Herbicides Fungicides
Innovation Rate Moderate, rising with biopesticide focus High in biotech High in chemical and biotechnological solutions
Patent Focus Novel chemistries, resistance-breaking Biotech, gene editing Biocontrols, resistance management
Regulatory Pressure Stringent Increasing Stringent

Conclusion & Strategic Implications

The insecticide landscape under the NLM MeSH classification is characterized by a dynamic patent environment emphasizing resistance management, environmental safety, and biotechnological integration. Industry players should monitor patent filings, especially in biopesticides and nanotech areas, to capitalize on technological trends and regulatory climate shifts. Mergers, acquisitions, and licensing will continue shaping competitiveness, with patent portfolios serving as key strategic assets.


Key Takeaways

  • The global insecticide market is projected to grow at a CAGR of approximately 4% driven by agriculture and public health needs.
  • Patent filings have steadily increased, with active innovation in biopesticides, nanotechnology, and resistance management.
  • Major patent holders include Bayer, Syngenta, BASF, Sumitomo Chemical, and FMC, focusing on sustainable and resistance-breaking solutions.
  • Regulatory drivers and environmental concerns are shaping the rapid adoption of green chemistry and novel delivery technologies.
  • Geographic concentration persists, with China, the USA, and Japan leading patent activity and market influence.

FAQs

1. What are the most active areas of patent innovation in insecticides?
Biopesticides (microbial and botanical formulations), nanotechnologies, resistance-breaking compounds, and combined chemical-biological agents dominate recent patent filings.

2. How does patent expiration impact the insecticide market?
Patent expiration leads to increased generic competition, potentially reducing prices and stimulating innovation to replace aging products.

3. Are there significant regional differences in insecticide patent filings?
Yes. China and the USA are the most active, with Europe emphasizing environmentally friendly and regulatory compliant innovations.

4. What role does resistance management play in current patent strategies?
It is a core focus, with companies patenting novel modes of action, synergists, and integrated formulations to extend product lifecycles.

5. How are regulatory policies influencing the patent landscape?
Stringent environmental and safety regulations prioritize green chemistry and biopesticides, prompting more patent applications in these areas.


References

  1. Grand View Research, "Insecticide Market Size, Share & Trends Analysis Report," 2023-2028.
  2. Industry Patent Trends Dataset, Thomson Innovation, 2018-2022.
  3. EPA, "Insecticide Resistance Management," 2021.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.